Background and Aim: Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease that has affected every aspect of life in many countries Previous studies suggested that the role of vitamin D in the immune system has certain significances in managing COVID-19 patients This study aims to report the level of vitamin D in COVID-19 patients Methods: We collected a series of confirmed cases from period of March through May 2020 The data collected including clinical symptoms, clinical signs, and laboratory examinations from 10 COVID-19 patients in Bethesda Hospital, Yogyakarta, Indonesia This study used ELFA (enzyme-linked fluorescent assay) to measure vitamin D levels in serum or plasma The collected data was analysed descriptively Results: This study examined 10 patients with mean age of 49 6, ranging from 14 to 73 years old and most common age group was &lt;60 years (60%) The gender ratio was equal between men and women (50:50) Most common symptoms were fatigue (60%) and fever (50%), whereas hypertension (40%) was the most common comorbidity Most of patients (90%) had vitamin D deficiency (&lt;20 ng/mL) and only 1 patient (10%) had insufficient vitamin D levels (&lt;30 ng/mL) Conclusion: All of the COVID-19 patients in this study had suffered a decreased vitamin D levels, and more common in non-elderly patients This is a novel findings of vitamin D deficiency in COVID-19 and has not been reported yet Physicians should be aware in managing COVID-19 patients, especially the risk of vitamin D deficiency
Coronavirus Disease 2019 (COVID-19) and Vitamin D Status: Is there any Opportunity for Intervention?